Funding

Direktlink:
Contents; Accesskey: 2 | Hauptnavigation; Accesskey: 3 | Servicenavigation; Accesskey: 4
Layoutbild
 
 

Funding

Results: 61
Sorted by:
  1 ||| ...
Funding
On the path to the bioeconomy: the federal government is providing support for growing numbers of research projects in industrial biotechnology. Pictured here, a 5000-litre fermenter at BASF. 28.03.2012

Federal government: Increasingly important role for white biotechnology

With the assistance of federal government support strategies, industrial biotechnology is taking on an increasingly important role. This is underlined by the response to a brief parliamentary enquiry from the SPD fraction in the Bundestag.

The award-winning life scientists in 2012: From top left: Matthias Mann, Michael Brecht, Nikolaus Rajewsky; below, from left: Christian Kurts, Gunther Hartmann. 17.12.2011

2012 Leibniz Prize goes to five bioscientists

Five top researchers in the life sciences are among the winners of the 2012 Leibniz Prize. A neurophysiologist and a systems biologist from Berlin, a biochemist in Martinsried, and two immunologists from Bonn will share the prize, worth a total of 2.5 million euros.

This year, the Science Council will be approving new university buildings with a total value of 462 million euros. 23.07.2011

Science Council: 462 million euros for new research buildings

Every year, the Science Council appraises research buildings planned for construction at universities in Germany. Biotechnology is particularly well represented this year, making up seven of the 16 projects put forward for funding.

What biotechnological innovations will be required in the future? And where is there a pressing need for research? Questions such as these were at the foreground of the annual congress for the strategic process ‘Next Generation of Biotechnological Processes’. 15.07.2011

The biotechnology of tomorrow: The next stage in the strategic process

What will the biotechnology of the future look like? What steps in research and development will be required before this can be achieved? These are the kinds of questions being posed by the strategic process Biotechnology 2020+, which was launched by the Federal Ministry of Research in 2010. The recent second Annual Congress took a first stock of the process.

All participating parties met in Berlin for the official launch of the Health Centers (from left): Pierluigi Nicotera (DZNE), Thomas Eschenhagen, German Centre for Cardiovascular Research (DZHK), Otmar D. Wiestler (DKTK), Annette Schavan, Federal Minister for Education and Research, Werner Seeger (DZL), Martin Hrabé de Angelis (DZD ), Sebastian Suerbaum (DZI). 30.06.2011

Well positioned across Germany in the fight against widespread diseases

It's official: The six German Centers For Health Research have been given the starting signal to begin their work. The centers carry great expectations for the fight against common diseases; above all, it is hoped that results will now be transferred more speedily and smoothly from the laboratories to the patients.

Fluorescence-labelled membrane proteins made without the use of cells: These molecules often play an important role in diseases, making them an attractive point of attack for medicines. 30.03.2011

Cell-free manufacturing of biomolecules

Biotechnologists today use cells or microorganisms to produce protein-based drugs such as antibodies. With the research project ‘Biomolecules from the Production Line’, Fraunhofer researchers are now hoping to establish cell-free biotechnology as a new technology.

The go-ahead has been given in Berlin for new directions in health research: Federal Minister for Research Annette Schavan (centre), Federal Minister for Health Philipp Rösler (r) and Charité Chairman Karl-Max Einhäupl (l). 14.01.2011

Policy issue number one: Humans and their health

Medicine is the big issue of 2011: The Science Year is this time dedicated to humans and their health, and the Federal Government is hoping to bring a new emphasis to funding policy with its billions-strong supporting programme for health research.

The Federal Government is making available 5.5 billion for health research in the coming four years. Hopes are being invested in tailor-made therapies in the field of stem cell research. 20.12.2010

Health research supporting programme: 5.5 billion for improved medicine

The federal government has adopted a new health research program. The BMBF is investing around 5.5 billion euros in therapeutic approaches to common diseases, personalised medicine, and nutrition research up to 2014.

Want to promote bioeconomy: Reinhard Hüttl, Thomas Rachel, Robert Kloos, Holger Zinke, Helmut Born (left to right). 19.11.2010

Federal Government: 2.4 billion euros for the bioeconomy

The Federal Government is planning to make Germany a pioneer in the biobased economy, and is driving forward research with billions-strong funding across four ministries. 10 November in Berlin saw the official launch of the National Research Strategy BioEconomy 2030, and biotechnology is set to play an important role.

The Heads of the five partner institutions of the German Center for Diabetes Research: Michael Roden (German Diabetes Center), Hans-Georg Joost (German Institute of Human Nutrition), Michele Solimena (Dresden Technical University), Martin Hrabé de Angelis (Helmholtz Center Munich), Hans-Ulrich Häring (University of Tübingen). Source: Ingo Kniest 16.11.2010

German Center for Diabetes Research gets to work

After two years of preparation, the Federal Ministry of Research-initiated German Center for Diabetes Research in Munich has officially begun work. The association bundles expertise from five research institutions in Munich, Düsseldorf, Potsdam, Dresden, and Tübingen.

Results: 61
Sorted by:
  1 ||| ...